Redeye revises its estimates and valuation on the back of the Q4 2023 report, which came in below ou...
Redeye provides an update following Nitro Games' Q4 2023 report, which proved to be strong as prelim...
Redeye revises our forecast following TH1NG’s Q4 2023 report.
Redeye retains its positive view of Formpipe following a Q4 report largely matching our expectations...
Avslutar året i linje med våra estimat Omsättningen i kvartalet uppgick till 70,4 mkr vilket motsvar...
VibroSense redovisade en nettoomsättning om 0,57 MSEK (0,46), vilket var en ökning med 22,4 procent ...
Advenica close 2023 with a 25% increase in sales, primarily driven by substantial gains in the Desi...
As expected, Free2Move reported solid growth in Q4, achieving a 59% growth rate for the full year.
Sales in line, but 10% EBIT beat We lift '24e adj. EBIT 8% on lower opex assumptions +17% adj.
Redeye remains positive towards Avensia despite a soft Q4 report and reduced forecasts.
Exel’s Q4 figures remained very low as account activity is only now bottoming out after a challengin...
Aspo’s Q4 showed some positive trends while EBIT remained quite low.
Ahead of Atria’s Q4, due on 22 February, we maintain our estimates intact.
Bolaget fortsätter att växa tvåsiffrigt till en hög marginal och ett starkt kassaflöde.
Agency i linje med guidning och höga ambitioner i World TOURN Agency-intäkterna i Q4 (15 mkr) var i ...
Q4-resultatet visar tydliga tecken på förbättrad lönsamhet och kapitaleffektivitet Nettoomsättningen...
Redeye concludes that the figures in the Q4 2023 report from TH1NG align with the previously disclos...
Organic growth of 18% vs. cons. 9% Adj. EBITA SEK 162m, 2% below cons, in line with ABGSCe Surprisin...
Redeye adjusts its estimates and fair value range following Genovis’ year-end report, which came in ...
Redeye updates its outlook on Acarix following its year-end report 2023.
